Phase
Condition
Prostate Disorders
Prostate Cancer
Urologic Cancer
Treatment
N/AClinical Study ID
Ages 18-100 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- Histologically confirmed adenocarcinoma of the prostate. 2 The presence of the followingstudies: TRUS of the prostate gland, pelvis MRI, OSG.
3 Histological evaluation of prostate biopsy with assignment of the Gleason index.
4 Clinical stage T1-3N0M0 (AJCC 7th edition). 5 ECOG performance status 0-1 6 Age limit 18years. 7 Patient consent to participate in a clinical study.
Exclusion
Exclusion criteria:
Prior or concurrent lymphomatous/hematogenous malignancy or other invasive malignancyexcept nonmelanomatous skin cancer or any other cancer for which the patient has beencontinually disease-free for ≥ 5 years (e.g., carcinoma in situ of the bladder or oralcavity)
Distatnt metastases.
Metastases in the lymph nodes of prostate cancer.
Radical prostatectomy or cryodestruction of the prostate gland in history.
Radiation of a small pelvis in the anamnesis. Bilateral orchectomy history.
Unstable angina and/or congestive heart failure requiring hospitalization within thepast 6 months, transmural myocardial infarction within the past 6 months, acutebacterial or fungal infection requiring IV antibiotics, chronic obstructive pulmonarydisease exacerbation or other respiratory illness requiring hospitalization orprecluding study treatment, hepatic insufficiency resulting in clinical jaundiceand/or coagulation defects.
Study Design
Study Description
Connect with a study center
Tatarstan Cancer Cente
Kazan, Tatarstan 420029
Russian FederationSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.